Why GLP-1 Drugs Work Better for Some People Than Others
A contrarian look at why GLP-1 drugs work differently, what the new genetics paper actually shows, and what patients should do with that information.
Retatrutide Phase 3 Diabetes Results: What They Actually Show
Retatrutide’s phase 3 diabetes data look strong on A1C and weight loss. Here is what the trial showed, what most coverage misses, and what patients should do now.
Coming Off Mounjaro (Tirzepatide): What to Expect, Week By Week
Stopping Mounjaro? Appetite often returns as tirzepatide clears (~4–5 weeks). Here’s what studies show about regain, and a calm off-ramp plan.